Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. ICLR
4. JPM
5. LAES
6. NNE
7. IONS
8. IBM
9. DRI
10. SPY

Go back to Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
(NASDAQ: TNYA) Delayed: 0.73 --0 (-0%)
Previous Close $0.73    52 Week High $ 
Open $0.73    52 Week Low $ 
Day High $0.73    P/E N/A 
Day Low $0.73    EPS $ 
Volume 46,313